Metabolic Acidosis: Complications

The following are the major diseases or complications that may be contributed to by metabolic (metabolic-related) acidosis:

Blood, hematopoietic organs – Immune system (D50-D90).

  • Loss of activity of NK cells (natural killer cell; natural killer cells).
  • Inhibition of lymphocyte proliferation (infection defense).
  • Erythropoietin resistance (renal anemia).

Endocrine, nutritional, and metabolic diseases (E00-E90).

  • Increase in parathyroid hormone (increase in ionized calcium).
  • Diabetes mellitusType ” (due toInsulin resistance ↓)
  • Increased protein catabolism
  • Insulin resistance ↓
  • Increase in endogenous corticoid secretion.
  • Increase in extracellular potassium (hyperkalemia (excess potassium)).
  • Increase in the inonized calcium

Infectious and parasitic diseases (A00-B99).

  • At pH < 7.0, T cells (= T lymphocytes) can no longer kill tumor cells (increased risk of cancer) – this also increases the tendency to infections
  • Reduction of ATP-mediated dissolution of tumor cells.

Musculoskeletal system and connective tissue (M00-M99).

  • Arthralgia (joint pain)
  • Muscle loss
  • Myalgia (muscle pain)
  • Osteopenia (reduction in bone density; precursor to osteoporosis); osteoporosis (bone loss).

Neoplasms – tumor diseases (C00-D48).

  • At pH < 7.0, T cells (= T lymphocytes) can no longer kill tumor cells (increased risk of cancer) – this also increases the tendency to infections

Symptoms and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99).

  • Hypercalcemia (calcium excess).
  • Weakness in performance

Genitourinary system (kidneys, urinary tract – sex organs) (N00-N99)

Other consequences

  • Decrease in enzyme activities
  • Diffusion disorders and thus reduced supply of tissues with nutrients and vital substances (macro- and micronutrients).
  • Osmotic change (swelling and deformation) of cells.
  • Deterioration of oxygen utilization (oxygen use) and thus deterioration of organ functions (heart, kidneys, etc.)
  • Decrease in vascular muscle response to catecholamines.